Acute aortic thrombosis in patients receiving cisplatin-based chemotherapy

Author(s): Fernandes DD, Louzada ML, Souza CA, Matzinger F

Abstract

The increased risk of thrombosis in patients with active cancer has multiple causes. Acute thrombosis of the aorta is an exceedingly rare but potentially devastating complication in patients with cancer receiving cisplatin-based chemotherapy. Prompt diagnosis and definitive treatment are imperative to decrease morbidity and mortality. Early diagnosis is difficult because initial presentation is often nonspecific, requiring a high degree of clinical suspicion. We report 4 cases of acute thrombosis of the abdominal aorta in patients with cancer receiving cisplatin-based chemotherapy. We review the clinical aspects, recommended investigation, and treatment of this potentially fatal complication.

Similar Articles

Cardiotoxicity of cytotoxic drugs

Author(s): Schimmel K, Richel D, Van-Den BRB, Guchelaar HJ

Lung cancer as a cardiotoxic state:a rewiev

Author(s): Pérez-Callejo D, Torrente M, Brenes MA, Núñez B, Provencio M

Characterization of cardiovascular alterations induced by different chronic cisplatin treatments

Author(s): Herradón E, González C, Uranga JA, Abalo R, Martín MI, et al.

Cardiovascular morbidity in long-term survivors of metastatic testicular cancer

Author(s): Meinardi MT, Gietema JA, Van-der GWT, Van-Veldhuisen DJ, Runne MA, et al.

Cisplatin-induced cardiotoxicity– two case reports

Author(s): Sawant J, Prakruthi AD, Daddi J, Ghosh A, Joshi A, et al.

Cardiovascular toxicity induced by chemotherapy,targeted agents and radiotherapy: ESMO Clinical Practice Guidelines

Author(s): Curigliano G, Cardinale D, Suter T , Plataniotis G, De Azambuja E, et al.